Table 5.
No pre-spill diagnosis of lung disease (n=5,435) | Pre-spill diagnosis of lung disease (n=853) | ||||||
---|---|---|---|---|---|---|---|
| |||||||
Lung function | THc Level (ppm) | n(%) | Mean differences (95% CI)* | p-value | n(%) | Mean differences (95% CI)* | p-value |
FEV1, mL | |||||||
Level 1 (≤0.29) | 783 (14.41) | Ref | Ref | 130 (15.24) | Ref | Ref | |
Level 2 (0.30–0.99) | 2022 (37.20) | −3 (−49, 43) | 0.91 | 312 (36.58) | −24 (−154, 105) | 0.71 | |
Level 3 (1.00–2.99) | 1816 (33.41) | 44 (−4, 92) | 0.07 | 297 (34.82) | −20 (−150, 111) | 0.77 | |
Level 4 (≥3.00) | 814 (14.98) | −15 (−71, 41) | 0.60 | 114 (13.36) | −26 (−188, 135) | 0.75 | |
FVC, mL | |||||||
Level 1 (≤0.29) | 783 (14.41) | Ref | Ref | 130 (15.24) | Ref | Ref | |
Level 2 (0.30–0.99) | 2022 (37.20) | −4 (−58, 50) | 0.88 | 312 (36.58) | 34 (−113, 181) | 0.65 | |
Level 3 (1.00–2.99) | 1816 (33.41) | 48 (−8, 104) | 0.09 | 297 (34.82) | −13 (−161, 135) | 0.87 | |
Level 4 (≥3.00) | 814 (14.98) | 21 (−44, 87) | 0.52 | 114 (13.36) | −30 (−214, 154) | 0.75 | |
FEV1/FVC% | |||||||
Level 1 (≤0.29) | 783 (14.41) | Ref | Ref | 130 (15.24) | Ref | Ref | |
Level 2 (0.30–0.99) | 2022 (37.20) | 0.15 (−0.38, 0.68) | 0.58 | 312 (36.58) | −1.30 (−2.95, 0.35) | 0.12 | |
Level 3 (1.00–2.99) | 1816 (33.41) | 0.27 (−0.28, 0.83) | 0.34 | 297 (34.82) | −0.29 (−1.96, 1.40) | 0.73 | |
Level 4 (≥3.00) | 814 (14.98) | −0.62 (−1.27, 0.03) | 0.06 | 114 (13.36) | −0.25 (−2.31, 1.82) | 0.81 |
Abbreviations: THc Level, maximum ordinal total hydrocarbon exposure level; ppm, parts per million; CI, confidence interval
Model adjusted for: age, height, height2, weight, gender, ethnicity, race, pre-spill diabetes, education, employment, other oil industry experience, previous oil spill clean-up, residential proximity to Gulf Coast, smoking, secondhand smoke